Athersys Inc. is a biopharmaceutical company that is focused in the field of regenerative medicine. It is engaged in the discovery and development of best-in-class therapies designed to extend and enhance the quality of human life.


Updates from The Motley Fool

Latest updates on Athersys from Fool.com.


Stock Performance

View Interactive ATHX Charts
Sponsored by

Key Data Points

Primary metrics and data points about Athersys.
Current Price: $1.42
Prev Close: $1.44
Open: $1.44
Bid: $1.40
Ask: $1.44
Day's Range: $1.42 - $1.44
52wk Range: $1.02 - $2.60
Volume: 245,816
Avg Vol 728,872
Market Cap: $158M
P/E (ttm): -4.80
EPS (ttm): ($0.30)
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Athersys.
CAPS Rating 1 out of 5
 
78 Outperform
19 Underperform
CAPS All Stars
 
3 Outperform
10 Underperform

How do you think Athersys will perform against the market?



You pick for Athersys is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Gil Van Bokkelen, CEO

0% Approve

Based on 0 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Athersys.

Athersys Inc. is a biopharmaceutical company that is focused in the field of regenerative medicine. It is engaged in the discovery and development of best-in-class therapies designed to extend and enhance the quality of human life.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers